drugset / Trial / NCT01165931
Coronary Vasomotor Response After Riociguat Exposure
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of the study is to assess the effects of intracoronary Riociguat on coronary blood flow in subjects with coronary artery disease and to compare this effect with the intracoronary nitroglycerin, a coronary vasodilator widly used to treat patients with coronary artery disease.
Timeline
- Start
- 2012-05
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riociguat | Other / unclassified | 0.1 mg | Other |